DISCO Pharmaceuticals is based in Boston. It has raised $38M in total funding. Latest round: Seed.
DISCO Pharmaceuticals is based in Boston. DISCO Pharmaceuticals has raised $38M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in December 2025. The round record for DISCO Pharmaceuticals runs through 2025; nothing later has been disclosed. Investors on record include Ackermans & van Haaren, NRW.Bank, Sofinnova Partners, AbbVie Ventures, M Ventures, Panakes Partners. 6 distinct backers are named across the disclosed rounds.
DISCO Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026